Equities

Indegene Ltd

Indegene Ltd

Actions
IndustrialsIndustrial Support Services
  • Price (INR)640.30
  • Today's Change2.25 / 0.35%
  • Shares traded129.25k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 10:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. The Company operates through four segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Its Enterprise Commercial Solutions segment primarily involves assisting life sciences companies with their digital marketing operations. Its Omnichannel Activation solutions segment helps life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Under its Enterprise Medical Solutions segment, it establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. Others segment offers enterprise clinical solutions and consultancy services.

  • Revenue in INR (TTM)27.10bn
  • Net income in INR3.73bn
  • Incorporated1998
  • Employees4.37k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Teamlease Services Ltd102.54bn1.04bn45.69bn2.12k44.005.4128.990.445661.9461.946,115.59503.495.15--14.7548,436,510.005.205.7710.5810.49----1.011.26--5.680.13050.0018.4415.950.72622.7312.76--
SIS Ltd126.10bn1.58bn54.89bn163.74k35.062.1016.470.435310.8610.86867.07181.252.044.266.80770,088.302.565.684.739.7698.9799.041.262.841.182.970.39192.028.0711.57-45.14-2.5113.62--
Sundaram Finance Holdings Ltd3.16bn5.71bn66.53bn193.0011.731.1929.1321.0825.7025.7014.20252.630.0631--50.4216,351,190.004.511.914.511.9199.64--71.4545.32----0.00326.45219.6223.87124.4331.14-19.0637.70
Ion Exchange (India) Ltd25.48bn2.16bn77.67bn2.39k34.668.2030.293.0518.2318.23214.8977.031.085.823.0510,664,290.009.149.6118.4923.8737.5137.648.448.901.3121.090.164225.8118.0115.10-0.367824.6031.4327.23
Cms Info Systems Ltd24.37bn3.60bn78.96bn593.0022.183.7615.323.2421.8121.81147.57128.820.95283.752.9241,094,440.0014.0813.4917.4517.7188.4088.7914.7814.112.9027.300.0814--18.2819.9516.7930.6529.47--
Quess Corp Ltd199.34bn3.55bn95.22bn8.73k27.193.2614.640.477723.5623.561,325.26196.363.1117.026.7022,823,510.005.731.8510.513.3998.3894.591.840.70381.444.140.1828--11.3217.5023.811.591.54--
Eureka Forbes Ltd23.20bn1.24bn109.84bn2.63k88.722.5461.204.746.406.40119.42223.210.37343.1912.718,809,390.002.00--2.39--58.89--5.36--0.439125.230.0179--5.02--260.12------
Rites Ltd23.53bn3.98bn131.52bn1.81k36.3410.1826.395.597.537.5339.1926.880.402363.862.6613,005,860.007.509.2215.5419.2552.3954.9718.6322.211.57--0.003879.86-6.673.68-15.98-0.6084-1.9917.66
Indegene Ltd27.10bn3.73bn153.35bn4.37k38.246.4934.215.6616.7616.76121.9898.74------6,204,946.00------------13.75------0.036--12.29--26.53------
eClerx Services Limited31.33bn5.21bn155.72bn17.00k31.127.6023.884.97106.53106.53640.30436.001.20125.065.661,842,968.0019.8918.4322.6521.4097.7295.2816.6117.805.2724.710.12381.0410.4915.384.6317.515.278.45
BLS International Services Ltd18.73bn4.18bn157.15bn357.0037.6411.0032.198.3910.1510.1545.5134.711.05342.3437.4452,472,580.0024.7220.7132.1824.0650.8234.9323.4414.013.4247.470.184412.7110.5915.8455.8924.3615.5551.57
Computer Age Management Services Ltd12.97bn4.23bn223.39bn6.14k52.8621.6945.4817.2385.7685.76262.59209.020.9398--20.642,113,628.0030.3927.2637.5033.2919.5490.6532.3429.42--61.160.084263.5316.9510.3823.9822.071.81--
Firstsource Solutions Ltd69.84bn5.36bn233.96bn27.94k44.516.0028.493.357.637.6399.4356.571.04--5.342,499,479.007.998.8311.1612.20----7.678.25--6.440.366148.255.2110.610.19646.38-4.7911.84
Data as of Nov 22 2024. Currency figures normalised to Indegene Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

4.66%Per cent of shares held by top holders
HolderShares% Held
FIL Investment Management (Singapore) Ltd.as of 30 Sep 20244.20m1.75%
Capital Research & Management Co. (World Investors)as of 30 Sep 20242.50m1.05%
SBI Funds Management Ltd.as of 31 Oct 20241.32m0.55%
DSP Asset Managers Pvt. Ltd.as of 31 Oct 2024752.94k0.32%
Jupiter Asset Management Ltd.as of 31 Jul 2024636.77k0.27%
Helios Capital Asset Management (India) Pvt. Ltd.as of 31 Oct 2024494.26k0.21%
Invesco Asset Management (India) Pvt Ltd.as of 31 Oct 2024450.67k0.19%
Capital Research & Management Co. (Global Investors)as of 30 Sep 2024358.18k0.15%
Edelweiss Asset Management Ltd.as of 31 Oct 2024241.94k0.10%
Baroda BNP Paribas Asset Management India Pvt Ltd.as of 31 Oct 2024192.42k0.08%
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.